Related Experiment Videos
Multidrug resistance reversal in childhood malignancies--potential for a real step forward?
1Institute of Cancer Research, Royal Marsden NHS Trust, Surrey, U.K.
European Journal of Cancer (Oxford, England : 1990)
|April 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Relapsed intracranial ependymoma in children in the UK: patterns of relapse, survival and therapeutic outcome.
European journal of cancer (Oxford, England : 1990)·2009
Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.
British journal of haematology·2007
The development of functional imaging in the diagnosis, management and understanding of childhood brain tumours.
Pediatric blood & cancer·2004
Acute neurotoxicity in children with advanced stage B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukaemia treated with the United Kingdom children cancer study group 9002/9003 protocols.
European journal of cancer (Oxford, England : 1990)·2004
Recruiting children into cancer trials--role of the United Kingdom Children's Cancer Study Group (UKCCSG).
British journal of cancer·2003
Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?
European journal of cancer (Oxford, England : 1990)·2026
Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.
European journal of cancer (Oxford, England : 1990)·2026
Diagnostic pitfalls and unmet needs in neuroendocrine neoplasms: The added value of collegial expert pathology review through the national TENpath network.
European journal of cancer (Oxford, England : 1990)·2026
Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
European journal of cancer (Oxford, England : 1990)·2026
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
European journal of cancer (Oxford, England : 1990)·2026
Development of an age specific EORTC questionnaire to assess the health-related quality of life (HRQOL) of children with cancer aged 8-14 years - a mixed-methods content elicitation phase I & II EORTC QLG study.
European journal of cancer (Oxford, England : 1990)·2026
Regulatory roles of pyroptosis-associated lncRnas in breast cancer progression and immune microenvironment.
Cell cycle (Georgetown, Tex.)·2026
Insights Into the Mechanisms of Biological Aging That Guide Translational and Clinical Research.
Aging medicine (Milton (N.S.W))·2026
Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.
International journal of nanomedicine·2026
Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.
International journal of pharmaceutics: X·2026
Enhanced anticancer efficacy of Pa-MAP 1.9 peptide-coated silver nanostars on breast cancer cells.
Materials today. Bio·2026